Tissue Penetration of Antibiotics in Obesity

NCT00752908 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 27

Last updated 2019-09-09

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate cefoxitin pharmacokinetics in obese surgical patients.

Conditions

Sponsors & Collaborators

  • Washington University School of Medicine

    lead OTHER

Principal Investigators

  • Evan D Kharasch, MD, PhD · Washington University School of Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-02-29
Primary Completion
2011-06-30
Completion
2011-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00752908 on ClinicalTrials.gov